Tyrosine kinase inhibitors in patients with radioiodine-refractory, differentiated thyroid cancer Is there an optimal timepoint for their use?
Rendl, G; Schweighofer-Zwink, G; Pirich, C
AUST J CLIN ENDOCR M. 2023;
Originalarbeiten (Zeitschrift)

Prognostic value of 2-[ 18 F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy
Schweighofer-Zwink, G; Manafi-Farid, R; Kölblinger, P; Hehenwarter, L; Harsini, S; Pirich, C; Beheshti, M;
Eur J Radiol. 2022; 146: 110107
Originalarbeiten (Zeitschrift)

Incremental Impact of [
Szigeti, F; Schweighofer-Zwink, G; Meissnitzer, M; Hauser-Kronberger, C; Hitzl, W; Kunit, T; Forstner, R; Pirich, C; Beheshti, M
Mol Imaging Biol. 2022; 24(1):50-59
Originalarbeiten (Zeitschrift)

Positron emission tomography-magnetic resonance imaging as a research tool in musculoskeletal conditions.
van den Wyngaert, T; de Schepper, S; Elvas, F; Seyedinia, SS; Beheshti, M;
Q J Nucl Med Mol Imaging. 2022; 66(1):15-30
Übersichtsarbeiten

Ga-DOTATOC PET/CT Follow Up after Single or Hypofractionated Gamma Knife ICON Radiosurgery for Meningioma Patients.
Barone, F; Inserra, F; Scalia, G; Ippolito, M; Cosentino, S; Crea, A; Sabini, MG; Valastro, L; Patti, IV; Mele, S; Acquaviva, G; Tocco, A; Tamburo, M; Graziano, F; Tomasi, OS; Maugeri, R; Iacopino, G; Cicero, S; Strigari, L; Umana, GE;
Brain Sci. 2021; 11(3):
Originalarbeiten (Zeitschrift)

2-[ 18 F]FDG PET/CT radiomics in lung cancer: An overview of the technical aspect and its emerging role in management of the disease
Manafi-Farid, R; Karamzade-Ziarati, N; Vali, R; Mottaghy, FM; Beheshti, M;
Methods. 2021; 188: 84-97.
Übersichtsarbeiten

Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends
Manafi-Farid, R; Ranjbar, S; Araghi, ZJ; Pilz, J; Schweighofer-Zwink, G; Pirich, C; Beheshti, M
CANCERS. 2021; 13(21): 5360
Übersichtsarbeiten

The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma.
Seidensaal, K; Mattke, M; Haufe, S; Rathke, H; Haberkorn, U; Bougatf, N; Kudak, A; Blattmann, C; Oertel, S; Kirchner, M; Buesch, C; Kieser, M; Herfarth, K; Kulozik, A; Debus, J; Uhl, M; Harrabi, SB;
Radiother Oncol. 2021; 159: 8-16.
Originalarbeiten (Zeitschrift)

[F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
Walter, F; Jell, C; Zollner, B; Andrae, C; Gerum, S; Ilhan, H; Belka, C; Niyazi, M; Roeder, F;
Strahlenther Onkol. 2021; 197(9):78-790
Originalarbeiten (Zeitschrift)

Multiphasic
Beheshti, M; Manafi-Farid, R; Geinitz, H; Vali, R; Loidl, W; Mottaghy, FM; Langsteger, W;
J Nucl Med. 2020; 61(10):148-1490
Originalarbeiten (Zeitschrift)

Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1).
Semrau, S; Schmidt, D; Hecht, M; Haderlein, M; Kitzsteiner, C; Müller, S; Traxdorf, M; Agaimy, A; Iro, H; Kuwert, T; Fietkau, R;
Oral Oncol. 2020; 100:104479
Originalarbeiten (Zeitschrift)

Para-aortal Ganglion Mimicking a Lymph Node Metastases on 68Ga-PSMA PET/CT.
Zwink, GS; Rendl, G; Schmeller, N; Pirich, C
CLIN NUCL MED. 2020; 45(11): 883-885.
Fallberichte

Molecular imaging of bone metastases using tumor-targeted tracers.
Karamzade-Ziarati, N; Manafi-Farid, R; Ataeinia, B; Langsteger, W; Pirich, C; Mottaghy, FM; Beheshti, M;
Q J Nucl Med Mol Imaging. 2019; 63(2):136-149
Übersichtsarbeiten

[Imaging of parathyroid adenomas with F‑18 choline PET-CT].
Schweighofer-Zwink, G; Hehenwarter, L; Rendl, G; Rettenbacher, L; Langsteger, W; Beheshti, M; Pirich, C;
Wien Med Wochenschr. 2019; 169(1-2):15-24
Originalarbeiten (Zeitschrift)

F-Sodium Fluoride PET/CT and PET/MR Imaging of Bone and Joint Disorders.
Beheshti, M;
PET Clin. 2018; 13(4):477-490
Übersichtsarbeiten

F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with
Beheshti, M; Hehenwarter, L; Paymani, Z; Rendl, G; Imamovic, L; Rettenbacher, R; Tsybrovskyy, O; Langsteger, W; Pirich, C;
Eur J Nucl Med Mol Imaging. 2018; 45(10):1762-1771
Originalarbeiten (Zeitschrift)

Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survival.
Hegemann, NS; Koepple, R; Walter, F; Boeckle, D; Fendler, WP; Angele, MK; Boeck, S; Belka, C; Roeder, F;
Strahlenther Onkol. 2018; 194(5): 435-443.
Originalarbeiten (Zeitschrift)

Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
Schoen, M; Braun, T; Manava, P; Ludwigs, S; Lell, M;
Nuklearmedizin. 2018; 57(2):50-55
Originalarbeiten (Zeitschrift)

Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
Zandieh, S; Bernt, R; Mirzaei, S; Haller, J; Hergan, K;
J Nucl Cardiol. 2018; 25(4):1128-1134
Originalarbeiten (Zeitschrift)

68Ga-PSMA-HBED Uptake on Cervicothoracic (Stellate) Ganglia, a Common Pitfall on PET/CT.
Beheshti, M; Rezaee, A; Langsteger, W;
Clin Nucl Med. 2017; 42(3):195-196
Originalarbeiten (Zeitschrift)

Guideline for PET/CT imaging of neuroendocrine neoplasms with
Bozkurt, MF; Virgolini, I; Balogova, S; Beheshti, M; Rubello, D; Decristoforo, C; Ambrosini, V; Kjaer, A; Delgado-Bolton, R; Kunikowska, J; Oyen, WJG; Chiti, A; Giammarile, F; Sundin, A; Fanti, S;
Eur J Nucl Med Mol Imaging. 2017; 44(9):1588-1601
Originalarbeiten (Zeitschrift)

Therapy assessment of bone metastatic disease in the era of
Etchebehere, E; Brito, AE; Rezaee, A; Langsteger, W; Beheshti, M;
Eur J Nucl Med Mol Imaging. 2017; 44(Suppl 1):84-96
Übersichtsarbeiten

[(18)F]FDG PET accurately differentiates infected and non-infected non-unions after fracture fixation.
Wenter, V; Albert, NL; Brendel, M; Fendler, WP; Cyran, CC; Bartenstein, P; Friederichs, J; Müller, JP; Militz, M; Hacker, M; Hungerer, S;
Eur J Nucl Med Mol Imaging. 2017; 44(3): 432-440.
Originalarbeiten (Zeitschrift)

Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.
Beheshti, M; Rezaee, A; Geinitz, H; Loidl, W; Pirich, C; Langsteger, W;
J Nucl Med. 2016; 57(Suppl 3):55-60S
Originalarbeiten (Zeitschrift)

Sutureless, rapid deployment valves and stented bioprosthesis in aortic valve replacement: recommendations of an International Expert Consensus Panel.
Gersak, B; Fischlein, T; Folliguet, TA; Meuris, B; Teoh, KH; Moten, SC; Solinas, M; Miceli, A; Oberwalder, PJ; Rambaldini, M; Bhatnagar, G; Borger, MA; Bouchard, D; Bouchot, O; Clark, SC; Dapunt, OE; Ferrarini, M; Laufer, G; Mignosa, C; Millner, R; Noirhomme, P; Pfeiffer, S; Ruyra-Baliarda, X; Shrestha, M; Suri, RM; Troise, G; Diegeler, A; Laborde, F; Laskar, M; Najm, HK; Glauber, M;
Eur J Cardiothorac Surg. 2016; 49(3): 709-718.
Originalarbeiten (Zeitschrift)

IgG4-related disease: current challenges and future prospects
Lang, D; Zwerina, J; Pieringer, H
THER CLIN RISK MANAG. 2016; 12: 189-199.
Übersichtsarbeiten

18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis.
Stelzmueller, I; Huber, H; Wunn, R; Hodolic, M; Mandl, M; Lamprecht, B; Schinko, H; Fellner, F; Skanjeti, A; Giammarile, F; Colletti, PM; Rubello, D; Gabriel, M;
Clin Nucl Med. 2016; 41(4): e187-e194.
Originalarbeiten (Zeitschrift)

The diagnostic value of [(18)F]FDG PET for the detection of chronic osteomyelitis and implant-associated infection.
Wenter, V; Müller, JP; Albert, NL; Lehner, S; Fendler, WP; Bartenstein, P; Cyran, CC; Friederichs, J; Militz, M; Hacker, M; Hungerer, S;
Eur J Nucl Med Mol Imaging. 2016; 43(4):749-761
Originalarbeiten (Zeitschrift)

The relevance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diagnosing prosthetic graft infections post cardiac and proximal thoracic aortic surgery.
Guenther, SP; Cyran, CC; Rominger, A; Saam, T; Kazmierzcak, PM; Bagaev, E; Pichlmaier, M; Hagl, C; Khaladj, N;
Interact Cardiovasc Thorac Surg. 2015; 21(4):450-458
Originalarbeiten (Zeitschrift)

Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants.
Haroon, A; Zanoni, L; Celli, M; Zakavi, R; Beheshti, M; Langsteger, W; Fanti, S; Emberton, M; Bomanji, J;
Nucl Med Commun. 2015; 36(11):106-175
Originalarbeiten (Zeitschrift)

Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease.
Huber, H; Hodolic, M; Stelzmüller, I; Wunn, R; Hatzl, M; Fellner, F; Lamprecht, B; Rubello, D; Colletti, PM; Gabriel, M;
Nucl Med Commun. 2015; 36(5): 430-437.
Originalarbeiten (Zeitschrift)

Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations.
Huemer, M; Karall, D; Schossig, A; Abdenur, JE; Al Jasmi, F; Biagosch, C; Distelmaier, F; Freisinger, P; Graham, BH; Haack, TB; Hauser, N; Hertecant, J; Ebrahimi-Fakhari, D; Konstantopoulou, V; Leydiker, K; Lourenco, CM; Scholl-Bürgi, S; Wilichowski, E; Wolf, NI; Wortmann, SB; Taylor, RW; Mayr, JA; Bonnen, PE; Sperl, W; Prokisch, H; McFarland, R;
J Inherit Metab Dis. 2015; 38(5): 905-914.
Originalarbeiten (Zeitschrift)

FDG PET/CT dataset for navigation on femoral bone: a feasibility study.
Militz, M; Uhde, J; Christian, G; Linke, R; Morgenstern, M; Hungerer, S;
Biomed Tech (Berl). 2015; 60(6):551-555
Originalarbeiten (Zeitschrift)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
Rendl, G; Rettenbacher, L; Holzmannhofer, J; Datz, L; Hauser-Kronberger, C; Fastner, G; Ofner, D; Sedlmayer, F; Pirich, C;
Ann Nucl Med. 2015; 29(3): 284-294.
Originalarbeiten (Zeitschrift)

Positron emission tomography-computed tomography versus positron emission tomography-magnetic resonance imaging for diagnosis of oral squamous cell carcinoma: A pilot study.
Schlittenbauer, T; Zeilinger, M; Nkenke, E; Kreißel, S; Wurm, MC; Lell, M; Kuwert, T; Beck, M;
J Craniomaxillofac Surg. 2015; 43(10):2129-2135
Originalarbeiten (Zeitschrift)

The value of (18)F-fluoride PET/CT in the assessment of screw loosening in patients after intervertebral fusion stabilization.
Seifen, T; Rodrigues, M; Rettenbacher, L; Piotrowski, W; Holzmannhofer, J; Coy, MM; Pirich, C;
Eur J Nucl Med Mol Imaging. 2015; 42(2): 272-277.
Originalarbeiten (Zeitschrift)

Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.
Vali, R; Loidl, W; Pirich, C; Langesteger, W; Beheshti, M;
Am J Nucl Med Mol Imaging. 2015; 5(2):96-108
Übersichtsarbeiten

Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti, M; Haim, S; Zakavi, R; Steinmair, M; Waldenberger, P; Kunit, T; Nader, M; Langsteger, W; Loidl, W;
J Nucl Med. 2013; 54(6):833-840
Originalarbeiten (Zeitschrift)

Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick, HH; von Gall, C; Zeilinger, M; Wiesmüller, M; Braun, H; Ziegler, S; Kuwert, T; Uder, M; Dörfler, A; Kalender, WA; Lell, M;
Invest Radiol. 2013; 48(5): 280-289.
Originalarbeiten (Zeitschrift)

Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT.
Wiesmüller, M; Quick, HH; Navalpakkam, B; Lell, MM; Uder, M; Ritt, P; Schmidt, D; Beck, M; Kuwert, T; von Gall, CC;
Eur J Nucl Med Mol Imaging. 2013; 40(1):-21.
Originalarbeiten (Zeitschrift)

Value of (18)F NaF PET/CT in the Detection and Global Quantification of Cardiovascular Molecular Calcification as Part of the Atherosclerotic Process.
Basu, S; Beheshti, M; Alavi, A;
PET Clin. 2012; 7(3):32-39
Originalarbeiten (Zeitschrift)

18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Bauman, G; Belhocine, T; Kovacs, M; Ward, A; Beheshti, M; Rachinsky, I;
Prostate Cancer Prostatic Dis. 2012; 15(1):4-55
Übersichtsarbeiten

The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.
Nawara, C; Rendl, G; Wurstbauer, K; Lackner, B; Rettenbacher, L; Datz, L; Studnicka, M; Sedlmayer, F; Pirich, C;
Q J Nucl Med Mol Imaging. 2012; 56(2): 19-201.
Originalarbeiten (Zeitschrift)

Prolonged back pain attributed to suspected spondylodiscitis. The value of ¹⁸F-FDG PET/CT imaging in the diagnostic work-up of patients.
Seifen, T; Rettenbacher, L; Thaler, C; Holzmannhofer, J; Mc Coy, M; Pirich, C;
Nuklearmedizin. 2012; 51(5):194-200
Originalarbeiten (Zeitschrift)

Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept.
Beheshti, M; Saboury, B; Mehta, NN; Torigian, DA; Werner, T; Mohler, E; Wilensky, R; Newberg, AB; Basu, S; Langsteger, W; Alavi, A;
Hell J Nucl Med. 2011; 14(2):114-120
Originalarbeiten (Zeitschrift)

Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy Diagnostic value and the work-up of sentinel node negative patients
Dalus, K; Reitsamer, R; Holzmannhofer, J; Rendl, G; Pirich, C; Kronberger, C; Rettenbacher, L
NUKLEARMED-NUCL MED. 2011; 50(1): 33-38.
Originalarbeiten (Zeitschrift)

Carcinoma of unknown primary in the head and neck: comparison between positron emission tomography (PET) and PET/CT.
Keller, F; Psychogios, G; Linke, R; Lell, M; Kuwert, T; Iro, H; Zenk, J;
Head Neck. 2011; 33(11): 1569-1575.
Originalarbeiten (Zeitschrift)

Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
Langsteger, W; Balogova, S; Huchet, V; Beheshti, M; Paycha, F; Egrot, C; Janetschek, G; Loidl, W; Nataf, V; Kerrou, K; Pascal, O; Cussenot, O; Talbot, JN;
Q J Nucl Med Mol Imaging. 2011; 55(4):448-457
Originalarbeiten (Zeitschrift)

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
Beheshti, M; Imamovic, L; Broinger, G; Vali, R; Waldenberger, P; Stoiber, F; Nader, M; Gruy, B; Janetschek, G; Langsteger, W;
Radiology. 2010; 254(3):925-933
Originalarbeiten (Zeitschrift)

Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
Dirisamer, A; Halpern, BS; Flöry, D; Wolf, F; Beheshti, M; Mayerhoefer, ME; Langsteger, W;
Eur J Radiol. 2010; 73(2):294-299
Originalarbeiten (Zeitschrift)

Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.
Dirisamer, A; Halpern, BS; Flöry, D; Wolf, F; Beheshti, M; Mayerhoefer, ME; Langsteger, W;
Eur J Radiol. 2010; 73(2):324-328
Originalarbeiten (Zeitschrift)

[New aspects of MRI for diagnostics of large vessel vasculitis and primary angiitis of the central nervous system].
Saam, T; Habs, M; Cyran, CC; Grimm, J; Pfefferkorn, T; Schüller, U; Reiser, MF; Nikolaou, K;
Radiologe. 2010; 50(10):86-71
Originalarbeiten (Zeitschrift)

The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.
Beheshti, M; Vali, R; Waldenberger, P; Fitz, F; Nader, M; Hammer, J; Loidl, W; Pirich, C; Fogelman, I; Langsteger, W;
Mol Imaging Biol. 2009; 12(1):98-107
Originalarbeiten (Zeitschrift)

The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.
Beheshti, M; Vali, R; Waldenberger, P; Fitz, F; Nader, M; Hammer, J; Loidl, W; Pirich, C; Fogelman, I; Langsteger, W;
Mol Imaging Biol. 2009; 11(6):446-454
Originalarbeiten (Zeitschrift)

[Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference].
Kohlfürst, S; Markitz, M; Raunik, W; Eckel, HE; Kresnik, E; Hausegger, K; Salzwimmer, M; Gaggl, A; Chiari, F; Lind, P;
Laryngorhinootologie. 2009; 88(2): 84-90.
Originalarbeiten (Zeitschrift)